Alzheimer’s Association Welcomes U.S. FDA Traditional Approval of Leqembi

The Alzheimer’s Association celebrates today’s U.S. Food and Drug Administration (FDA) action to grant traditional approval of Leqembi for the treatment of early Alzheimer's disease with confirmation of elevated amyloid beta. This is the first traditional approval of an Alzheimer’s treatment that changes the underlying course of the disease.

Dementia care which makes daily life as normal as possible

• 1 Free, no-obligation consultation laying the foundations for your loved one’s care plan
• 2 Developing your loved one’s care plan coordinating with doctors and health professionals
• 3 Matching with a qualified care provider who are all carefully screened prior to placement

• Find out more
• Get support